Sponsored by
We already knew this - but strangely I hear of many patients who do not get Temozolomide at the same time as radiation for Anaplastic Astrocytomas. This article should hopefully change that.
Temozolomide Trial Shows Improved 5-Year Survival Rates in Anaplastic Glioma - See more at: http://www.onclive.com/conference-coverage/asco-2016/temozolomide-trial-shows-improved-5year-survival-rates-in-anaplastic-glioma#sthash.ukoMtPWX.dpuf